Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The soluble interleukin-2 receptor in rheumatic disease.

× No keyword cloud information.

17 in total

1. Evaluation of serum levels of soluble interleukin-2 receptor as an indicator of disease activity in systemic lupus erythematosus.

Authors: P Airŏ; S Braga; E Prati; D Brugnoni; M Bettinzioli; R Gorla; R Cattaneo
Journal: Clin Rheumatol Date: 1992-03 Impact factor: 2.980

Review 2. Regulation of apoptosis in immune cells.

Authors: J D Mountz; T Zhou; J Wu; W Wang; X Su; J Cheng
Journal: J Clin Immunol Date: 1995-01 Impact factor: 8.317

3. Soluble interleukin-2-receptor and interleukin-6 changes during low-dose methotrexate treatment in rheumatoid arthritis.

Authors: A Spadaro; V Riccieri; A Sili Scavalli; F Sensi; E Taccari; A Zoppini
Journal: Clin Rheumatol Date: 1996-03 Impact factor: 2.980

Review 4. Advances in interleukin 2 receptor targeted treatment.

Authors: J C Morris; T A Waldmann
Journal: Ann Rheum Dis Date: 2000-11 Impact factor: 19.103

5. Continuity of cytokine activation in patients with familial Mediterranean fever.

Authors: Sait Bagci; Bulent Toy; Ahmet Tuzun; Yuksel Ates; Murat Aslan; Ali Inal; Mustafa Gulsen; Necmettin Karaeren; Kemal Dagalp
Journal: Clin Rheumatol Date: 2004-05-01 Impact factor: 2.980

6. Serum levels of interleukin 1-beta, tumor necrosis factor-alpha, soluble interleukin 2 receptor and soluble CD8 in seronegative spondylarthropathies.

Authors: E Toussirot; P Lafforgue; J Boucraut; P Despieds; A Schiano; D Bernard; P C Acquaviva
Journal: Rheumatol Int Date: 1994 Impact factor: 2.631

7. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.

Authors: K L Lim; A C Jones; N S Brown; R J Powell
Journal: Ann Rheum Dis Date: 1993-06 Impact factor: 19.103

8. Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate.

Authors: C D Rose; P T Fawcett; K Gibney; R A Doughty; B H Singsen
Journal: Ann Rheum Dis Date: 1994-07 Impact factor: 19.103

9. Systemic amyloidosis AL with temporal artery involvement revealing lymphoplasmacytic malignancy in a man presenting as polymyalgia rheumatica.

Authors: P Lafforgue; E Senbel; D Figarella-Branger; J Boucraut; N Horschowsky; J F Pellissier; P C Acquaviva
Journal: Ann Rheum Dis Date: 1993-02 Impact factor: 19.103

10. Urine neopterin: a new parameter for serial monitoring of disease activity in patients with systemic lupus erythematosus.

Authors: K L Lim; K Muir; R J Powell
Journal: Ann Rheum Dis Date: 1994-11 Impact factor: 19.103